Novartis (NVS) November Options Open: Strategic Analysis for Traders

Traders now have access to November 20th options contracts for Novartis (NVS), providing new avenues for hedging and income generation. With the stock currently trading at $147.75, several strategic entries are emerging for both bullish and neutral investors looking to optimize their positions. The introduction of these contracts allows investors to utilize specific premium-collection strategies to either lower their entry cost or enhance total returns. These strategies are particularly relevant given the stock's current volatility profile and trading range over the last twelve months. For investors seeking to acquire shares, selling the $145.00 put contract—currently bidding at $7.20—could lower the effective cost basis to $137.80. This strike price represents an approximate 2% discount to the current market price. Analytical data suggests a 59% probability of the contract expiring worthless, which would result in a 4.97% return on the cash commitment, or 8.93% annualized. Conversely, shareholders may consider a covered call strategy using the $150.00 strike price. With a bid of $9.50, this approach offers a potential total return of 7.95% if the stock is called away by the November expiration. There is a 49% probability that this contract expires worthless, allowing the investor to retain both the shares and the collected premium, representing an 11.56% annualized boost. Market data indicates a slight discrepancy between implied and actual volatility. While the 12-month trailing volatility for NVS stands at 21%, implied volatility for the new contracts is higher, sitting at 24% for puts and 29% for calls.